Opinion|Videos|January 10, 2025
The Role of the Multidisciplinary Care Team in RCC
Panelists discuss the multidisciplinary team’'s role in supporting patients through a renal cell carcinoma n( RCC) diagnosis, addressing informational gaps as patients process their diagnosis, offering supportive strategies and resources, and highlighting the unique challenges faced by patients with clear cell RCC compared to with those with non–-clear cell RCC.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- What is the multidisciplinary team’'s role in supporting patients through an RCC diagnosis?
- How do you address informational gaps as patients process their diagnosis? What other supportive strategies and resources might you provide?
- What unique challenges might patients with clear cell RCC face as opposed to patients with non–-clear cell RCC?
Advertisement
Related to this article
A personalized ctDNA assay demonstrated 100% specificity but limited sensitivity for detecting recurrence after liver transplantation in HCC and CCA.
The FDA cleared the SpaceOAR Flex System, a hydrogel spacer used during prostate cancer radiotherapy, in a 510(k) supported by the HYDROSPACE trial.
Phase 2 ASPEN-06 data showed higher response rates with evorpacept added to trastuzumab, ramucirumab, and paclitaxel in HER2-positive gastric cancer.
In 62 patients with ICI-naive HPV16-Positive HNSCC, 17.7% experienced grade 3 or 4 treatment-related adverse events.
Ethan B. Ludmir, MD, details which cholangiocarcinoma subsets, by tumor location, may benefit most from neoadjuvant radiation before surgery.
Data from the phase BRUIN CLL-313 and BRUIN CLL-314 trials support the approval of pirtobrutinib for patients with CLL or SLL in China.
Clinicians must think a lot about how to make testing and novel treatment advances available for patients globally, according to Chul Kim, MD, MPH.
Daniel C. McFarland, DO, and Yesne Alici, MD, discussed medical aid in dying in cancer care, New York’s safeguards, and the role of psycho-oncology.
Advertisement
Advertisement
Trending on CancerNetwork
1
Neoadjuvant Radiation May Improve Tolerability in Cholangiocarcinoma
2
Defining the Role of Neoadjuvant Radiation in Cholangiocarcinoma
3
Distal Extrahepatic Cholangiocarcinoma May Gain From Neoadjuvant Radiation
4
Isatuximab-Based Therapy Shows “Impressive” PFS Projections in NDMM
5